Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prime Medicine (PRME) Cash from Operations (2021 - 2025)

Prime Medicine filings provide 5 years of Cash from Operations readings, the most recent being 37256000.0 for Q4 2025.

  • On a quarterly basis, Cash from Operations fell 329.34% to 37256000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 162564000.0, a 32.31% decrease, with the full-year FY2025 number at 162564000.0, down 32.31% from a year prior.
  • Cash from Operations hit 37256000.0 in Q4 2025 for Prime Medicine, down from 35039000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 16245000.0 in Q4 2024 to a low of 67707000.0 in Q1 2024.
  • Median Cash from Operations over the past 5 years was 39166000.0 (2023), compared with a mean of 35050294.12.
  • Biggest five-year swings in Cash from Operations: skyrocketed 137.03% in 2024 and later crashed 329.34% in 2025.
  • Prime Medicine's Cash from Operations stood at 13187000.0 in 2021, then crashed by 132.9% to 30713000.0 in 2022, then crashed by 42.82% to 43864000.0 in 2023, then skyrocketed by 137.03% to 16245000.0 in 2024, then plummeted by 329.34% to 37256000.0 in 2025.
  • The last three reported values for Cash from Operations were 37256000.0 (Q4 2025), 35039000.0 (Q3 2025), and 41412000.0 (Q2 2025) per Business Quant data.